{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T21:07:21Z","timestamp":1780002441880,"version":"3.53.1"},"reference-count":54,"publisher":"Japanese Society of Hypertension","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2008]]},"DOI":"10.1291\/hypres.31.2165","type":"journal-article","created":{"date-parts":[[2009,1,13]],"date-time":"2009-01-13T05:57:53Z","timestamp":1231826273000},"page":"2165-2175","source":"Crossref","is-referenced-by-count":13,"title":["Angiotensin Type 1 Receptor Blockade Prevents Cardiac Remodeling in Mice with Pregnancy-Associated Hypertension"],"prefix":"10.1291","volume":"31","author":[{"given":"Akira","family":"SAKAIRI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"ISHIDA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"HONJO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saki","family":"INABA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoko","family":"NAKAMURA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiro","family":"SUGIYAMA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichi","family":"YAGAMI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyoshi","family":"FUKAMIZU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"119","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2000.107928"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1210\/en.2003-0150"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00036.2005"},{"key":"4","unstructured":"4. Nasjletti A, Masson GMC: Studies on angiotensinogen formation in a liver perfusion system. Circ Res<\/i> 1972; 30<\/b>: 187-202."},{"key":"5","unstructured":"5. Tewksbury DA: Angiotensinogen-biochemistry and molecular biology. in Laragh JH, Brenner BM (eds): Hypertension: Pathophysiology, Diagnosis and Management. New York, Raven Press, 1990, pp 1197-1216."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Chen Y, Naftilan AJ, Oparil S: Androgen-dependent angiotensinogen and renin messenger RNA expression in hypertensive rats. Hypertension<\/i> 1992; 19<\/b>: 456-463.","DOI":"10.1161\/01.HYP.19.5.456"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Rubattu S, Quimby FW, Sealey JE: Tissue renin and prorenin increase in female cats during the reproductive cycle without commensurate changes in plasma, amniotic or ovarian follicular fluid. J Hypertens<\/i> 1991; 9<\/b>: 525-535.","DOI":"10.1097\/00004872-199106000-00008"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1126\/science.3529392"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Howard RB, Pucell AG, Bumpus FM, et al<\/i>: Rat ovarian renin: characterization and changes during the estrous cycle. Endocrinology<\/i> 1988; 123<\/b>: 2331-2340.","DOI":"10.1210\/endo-123-5-2331"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Brown MA, Wang J, Whitworth JA: The renin-angiotensin-aldosterone system in pre-eclampsia. Clin Exp Hypertens<\/i> 1997; 19<\/b>: 713-726.","DOI":"10.3109\/10641969709083181"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Baker PN, Pipkin FB, Symonds EM: Platelet angiotensin II binding and plasma renin concentration, plasma renin substrate and plasma angiotensin II in human pregnancy. Clin Sci<\/i> (Lond<\/i>) 1990; 79<\/b>: 403-408.","DOI":"10.1042\/cs0790403"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Baker PN, Pipkin FB, Symonds EM: Comparative study of platelet angiotensin II binding and the angiotensin II sensitivity test as predictors of pregnancy-induced hypertension. Clin Sci<\/i> (Lond<\/i>) 1992; 83<\/b>: 89-95.","DOI":"10.1042\/cs0830089"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1172\/JCI107462"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Chesley LC, Talledo E, Bohler CS, et al<\/i>: Vascular reactivity to angiotensin II and norepinephrine in pregnant and nonpregnant women. Am J Obstet Gynecol<\/i> 1965; 91<\/b>: 837-842.","DOI":"10.1016\/0002-9378(65)90462-X"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Crowley SD, Tharaux PL, Audoly LP, et al<\/i>: Exploring type I angiotensin (AT1) receptor functions through gene targeting. Acta Physiol Scand<\/i> 2004; 181<\/b>: 561-570.","DOI":"10.1111\/j.1365-201X.2004.01331.x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. AbdAlla S, Lother H, el Massiery A, et al<\/i>: Increased AT1<\/sub> receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness. Nat Med<\/i> 2001; 7<\/b>: 1003-1009.","DOI":"10.1038\/nm0901-1003"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1172\/JCI4106"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Zhou CC, Zhang Y, Irani RA, et al<\/i>: Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice. Nat Med<\/i> 2008; 14<\/b>: 855-862.","DOI":"10.1038\/nm.1856"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1126\/science.274.5289.995"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Saito T, Ishida J, Takimoto-Ohnishi E, et al<\/i>: An essential role for angiotensin II type 1a receptor in pregnancy-associated hypertension with intrauterine growth retardation. FASEB J<\/i> 2004; 18<\/b>: 388-390.","DOI":"10.1096\/fj.03-0321fje"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Takimoto-Ohnishi E, Saito T, Ishida J, et al<\/i>: Differential roles of renin and angiotensinogen in the feto-maternal interface to the development of complications of pregnancy. Mol Endocrinol<\/i> 2005; 19<\/b>: 1361-1372.","DOI":"10.1210\/me.2004-0158"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Furuya M, Ishida J, Inaba S, et al<\/i>: Impaired placental neovascularization in mice with pregnancy-associated hypertension. Lab Invest<\/i> 2008; 88<\/b>: 416-429.","DOI":"10.1038\/labinvest.2008.7"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M404149200"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Ishizaka N, Saito K, Mitani H, et al<\/i>: Iron overload augments angiotensin II−induced cardiac fibrosis and promotes neointima formation. Circulation<\/i> 2002; 106<\/b>: 1840-1846.","DOI":"10.1161\/01.CIR.0000031161.77536.02"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Garpvic VD, Hayman SR: Hypertension in pregnancy: an emerging risk factor for cardiovascular disease. Nat Clin Pract Nephrol<\/i> 2007; 11<\/b>: 613-622.","DOI":"10.1038\/ncpneph0623"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Abboud J, Murad Y, Chen-Scarabelli C, Saravolatz L, Scarabelli TM: Peripartum cardiomyopathy: a comprehensive review. Int J Cardiol<\/i> 2007; 118<\/b>: 295-303.","DOI":"10.1016\/j.ijcard.2006.08.005"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Hunter S, Robson SC: Adaptation of the maternal heart in pregnancy. Br Heart J<\/i> 1992; 68<\/b>: 540-543.","DOI":"10.1136\/hrt.68.12.540"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Mesa A, Carlos J, Hernandez A, et al<\/i>: Left ventricular diastolic function in normal human pregnancy. Circulation<\/i> 1999; 9<\/b>: 511-517.","DOI":"10.1161\/01.CIR.99.4.511"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Valensise H, Novelli GP, Vasapollo B, et al<\/i>: Maternal diastolic dysfunction and left ventricular geometry in gestational hypertension. Hypertension<\/i> 2001; 37<\/b>: 1209-1215.","DOI":"10.1161\/01.HYP.37.5.1209"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Novelli GP, Valensise H, Vasapollo B, et al<\/i>: Left ventricular concentric geometry as a risk factor in gestational hypertension. Hypertension<\/i> 2003; 41<\/b>: 469-475.","DOI":"10.1161\/01.HYP.0000058001.67791.0A"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Valensise H, Vasapollo B, Novelli GP, et al<\/i>: Maternal total vascular resistance and concentric geometry: a key to identify uncomplicated gestational hypertension. BJOG<\/i> 2006; 113<\/b>: 1044-1052.","DOI":"10.1111\/j.1471-0528.2006.01013.x"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Zheng J, Bird IM, Chen DB, et al<\/i>: Angiotensin II regulation of ovine fetoplacental artery endothelial functions: interactions with nitric oxide. J Physiol<\/i> 2005; 565<\/b>: 59-69.","DOI":"10.1113\/jphysiol.2004.082420"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Hanssens M, Keirse MJ, Spitz B, et al<\/i>: Angiotensin II levels in hypertensive and normotensive pregnancies. Br J Obstet Gynecol<\/i> 1991; 98<\/b>: 155-161.","DOI":"10.1111\/j.1471-0528.1991.tb13361.x"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Kalenga MK, Thomas K, de Gasparo M, et al<\/i>: Determination of renin, angiotensin converting enzyme and angiotensin II levels in human placenta, chorion and amnion from women with pregnancy induced hypertension. Clin Endocrinol<\/i> (Oxf<\/i>) 1996; 44<\/b>: 429-433.","DOI":"10.1046\/j.1365-2265.1996.703525.x"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Sadoshima J, Izumo, S: Molecular characterization of angiotensin II−induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circ Res<\/i> 1993; 73<\/b>: 413-423.","DOI":"10.1161\/01.RES.73.3.413"},{"key":"36","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.12.6391"},{"key":"37","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.2.931"},{"key":"38","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.37.24037"},{"key":"39","doi-asserted-by":"publisher","DOI":"10.1172\/JCI31044"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Burstein B, Nattel S: Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol<\/i> 2008; 51<\/b>: 802-809.","DOI":"10.1016\/j.jacc.2007.09.064"},{"key":"41","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117243"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Harada K, Sugaya T, Murakami K, Yazaki Y, Komuro I: Angiotensin II type 1A receptor knockout mice display less left ventricular remodeling and improved survival after myocardial infarction. Circulation<\/i> 1999; 100<\/b>: 2093-2099.","DOI":"10.1161\/01.CIR.100.20.2093"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Lijnen PJ, Petrov VV, Fagard RH: Angiotensin II−induced stimulation of collagen secretion and production in cardiac fibroblasts is mediated via<\/i> angiotensin II subtype 1 receptors. J Renin Angiotensin Aldosterone Syst<\/i> 2001; 2<\/b>: 117-122.","DOI":"10.3317\/jraas.2001.012"},{"key":"44","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000111831.50834.93"},{"key":"45","doi-asserted-by":"publisher","DOI":"10.1016\/0008-6363(96)88532-4"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Nakamura K, Fushimi K, Kouchi H, et al<\/i>: Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin II. Circulation<\/i> 1998; 98<\/b>: 794-799.","DOI":"10.1161\/01.CIR.98.8.794"},{"key":"47","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M409710200"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Skultetyova D, Filipova S, Riecansky I, et al<\/i>: The role of angiotensin type 1 receptor in inflammation and endothelial dysfunction. Recent Patents Cardiovasc Drug Discov<\/i> 2007; 2<\/b>: 23-27.","DOI":"10.2174\/157489007779606130"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Schulz R, Heusch G: Angiotensin II in the failing heart. Kidney Blood Press Res<\/i> 2005; 28<\/b>: 349-352 (Short Communication).","DOI":"10.1159\/000090189"},{"key":"50","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.30.151"},{"key":"51","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.28.727"},{"key":"52","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200317189"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Lu F, Longo M, Tamayo E, et al<\/i>: The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice. Am J Obstet Gynecol<\/i> 2007; 196<\/b>: 396.e1-396.e7.","DOI":"10.1016\/j.ajog.2006.12.024"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Zhou CC, Ahmad S, Mi T, et al<\/i>: Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via<\/i> angiotensin type 1 receptor and calcineurin\/nuclear factor of activated T-cell signaling. Hypertension<\/i> 2008; 51<\/b>: 1010-1019.","DOI":"10.1161\/HYPERTENSIONAHA.107.097790"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T05:48:02Z","timestamp":1558072082000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nature.com\/doifinder\/10.1291\/hypres.31.2165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":54,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1291\/hypres.31.2165","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008]]}}}